Intentional use of intra-arterial medications when venous access is not available.

Intentional use of intra-arterial medications when venous access is not available. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Intentional use of intra-arterial medications when venous access is not available. Abstract Text:

Gayatri Joshi,Joseph D Tobias,Gayatri Joshi,Joseph D Tobias,Gayatri Joshi,Joseph D Tobias,

The difficult or impossible establishment of venous access is occasionally encountered in the pediatric population, especially in patients exposed to repeated surgical procedures or those with underlying comorbid features. Potential options in such situations include the intramuscular, intraosseous (IO), and intratracheal administration of medications. Although IO access is accepted as the route of choice in emergency situations, its use is not universally accepted in the operating room setting when the administration of medications is nonemergent. We report the intentional and elective use of the intra-arterial (IA) administration of vecuronium, atropine, fentanyl, and fluid during the provision of anesthesia for two infants with severe cyanotic congenital heart disease in whom venous access could not readily be obtained. The potential role of IA administration of medications is discussed and previous reports from the literature are reviewed.

Intentional use of intra-arterial medications when venous access is not available. Publishing Authors By Initials

G Joshi,JD Tobias,G Joshi,JD Tobias,G Joshi,JD Tobias,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Intentional use of intra-arterial medications when venous access is not available. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Paediatric anaesthesia

VOLUME: 17

Page Numbers: 1198-202

Journal Abbreviation:

ISSN: 1155-5645

DAY: 7

MONTH: Dec

YEAR: 2007

Intentional use of intra-arterial medications when venous access is not available. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9206575

Intentional use of intra-arterial medications when venous access is not available. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Intentional use of intra-arterial medications when venous access is not available. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Intentional use of intra-arterial medications when venous access is not available.

AFFILIATION: School of Medicine, University of Missouri, Columbia, MO, USA.

Country: France

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Paediatr Anaesth

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Intentional use of intra-arterial medications when venous access is not available Related Publications

• 15. Reactions of calf thymus DNA with the electrophiles methylmercury(ii) nitrate, cis-dichlorodiammineplatinum(ii), and trans-dichlorodiammineplatinum(ii) studied using raman difference spectroscopy Evidence for the formation of c-DNA upon metalation.
• Acute subacute bacterial endocarditis.
• An unusual presacral tumor.
• An unusual presacral tumor.
• Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors.
• Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer : What is the Optimal Initiation Time for the Maximum Benefit?
• Bone fragility contributes to the risk of fracture in children, even after moderate and severe trauma.
• Cardiovascular device infections in dogs: report of 8 cases and review of the literature.
• Chancres of the tongue.
• Combined general and spinal anesthesia in an infant with single-ventricle physiology undergoing anorectoplasty for an imperforate anus.
• Diffraction-based density restraints for membrane and membrane-peptide molecular dynamics simulations.
• Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
• Hydroxyl radical at the air-water interface.
• Impaired growth plate function in bmp-6 null mice.
• Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
• Intentional use of intra-arterial medications when venous access is not available.
• Methyl group dynamics as a probe of the protein dynamical transition.
• Minimally invasive per-catheter patent ductus arteriosus occlusion in dogs using a prototype duct occluder.
• Neoplastic cell transformation by heavy charged particles.
• Optimal experimental design in chromatography.
• Perioperative care of the patient with osteogenesis imperfecta.
• Pro: dexmedetomidine should be used for infants and children undergoing cardiac surgery.
• Resuscitation apparatus. No. 2,453,475.
• TLRs in disease.
• The Amplatz canine duct occluder: a novel device for patent ductus arteriosus occlusion.
• The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
• The repair-misrepair model in radiobiology: comparison to other models.
• The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
• Tickbite granuloma.
• [Not Available.]